UK markets closed

AbbVie Inc. (ABBV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
161.57-2.22 (-1.36%)
As of 10:59AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 290.01B
Enterprise value 336.58B
Trailing P/E 48.75
Forward P/E 14.66
PEG ratio (5-yr expected) 0.43
Price/sales (ttm)5.34
Price/book (mrq)27.99
Enterprise value/revenue 6.19
Enterprise value/EBITDA 34.86

Trading information

Stock price history

Beta (5Y monthly) 0.56
52-week change 39.06%
S&P500 52-week change 322.38%
52-week high 3182.89
52-week low 3130.96
50-day moving average 3173.32
200-day moving average 3157.34

Share statistics

Avg vol (3-month) 35.7M
Avg vol (10-day) 35.83M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.11%
% held by institutions 171.78%
Shares short (15 Apr 2024) 413.54M
Short ratio (15 Apr 2024) 42.11
Short % of float (15 Apr 2024) 40.77%
Short % of shares outstanding (15 Apr 2024) 40.76%
Shares short (prior month 15 Mar 2024) 414.69M

Dividends & splits

Forward annual dividend rate 46.2
Forward annual dividend yield 43.79%
Trailing annual dividend rate 36.06
Trailing annual dividend yield 33.70%
5-year average dividend yield 44.40
Payout ratio 4178.27%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.02%
Operating margin (ttm)24.60%

Management effectiveness

Return on assets (ttm)7.78%
Return on equity (ttm)56.24%

Income statement

Revenue (ttm)54.4B
Revenue per share (ttm)30.77
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)N/A
EBITDA 26.29B
Net income avi to common (ttm)5.95B
Diluted EPS (ttm)3.36
Quarterly earnings growth (yoy)472.80%

Balance sheet

Total cash (mrq)18.07B
Total cash per share (mrq)10.23
Total debt (mrq)74.36B
Total debt/equity (mrq)924.06%
Current ratio (mrq)0.94
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)22.69B
Levered free cash flow (ttm)23.72B